Pilot Study for the Use of Photodynamic Therapy in the Treatment of Seborrheic Dermatitis

NCT03114111 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Seborrheic Dermatitis

Interventions

DRUG: aminolevulinic acid (ALA)
DRUG: Placebo

Sponsor

University of California, Davis